Verónica Casado-Vicente

Verónica Casado-Vicente

Auto-generated profile, based on publicly available information

Verónica Casado-Vicente

Parquesol University Health Center, Valladolid, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
RSRita Salvado Rita Salvado
Rita Salvado Rita Salvado
SSSandra Santos‐Minguez
Sandra Santos‐Minguez
CLCristina Lugones-Sanchez
Cristina Lugones-Sanchez
SGSusana Gonzalez‐Sánchez
Susana Gonzalez‐Sánchez
OTOlaya Tamayo-Morales
Olaya Tamayo-Morales
MIMIVAS investigators
MIVAS investigators

1 January 2025 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
SLSandra León-Herrera
Sandra León-Herrera
MSMario Samper-Pardo
Mario Samper-Pardo
BOBárbara Oliván-Blázquez
Bárbara Oliván-Blázquez
MBMaría Rosa Magallón Botaya
María Rosa Magallón Botaya
VCVerónica Casado-Vicente
Verónica Casado-Vicente
RSRafael Sánchez-Arizcuren
Rafael Sánchez-Arizcuren
Purpose: This study aims to analyze the medium‐term effectiveness of telerehabilitation in enhancing the quality of life for patients with Long COVID, using a mobile application (APP) called ReCOVery APP. The secondary purpose is to identify significant factors associated with an improvement in the quality of life and other secondary outcomes in this population. Methods: A randomized clinical trial was carried out with two parallel groups involving a total of 100 patients with Long COVID. The first one (control group, n = 48) continued with their usual treatment (TAU), established by their primary care doctor. The second one (intervention group, n = 52), in addition to continuing with their TAU, attended three sessions based on motivational methodology and used the ReCOVery APP for 6 months. The primary outcome was quality of life. Results: After 6 months, ReCOVery APP did not significantly improve the quality of life among Long COVID patients. Poor adherence to the APP was observed among the participants who tried it. Linear regression analyses revealed a significant relationship between the decrease in the number of symptoms and the improvement in mental health–related quality. Conclusions: While this research contributes valuable insights into the potential of telerehabilitation for Long COVID patients, the lack of significant improvement in quality of life underscores the need for future large‐scale studies. Such research should focus on identifying effective strategies to enhance adherence to digital interventions, such as increased professional support and personalized care approaches. Additionally, exploring the long‐term effects of telerehabilitation could provide a more comprehensive understanding of its role in managing Long COVID. Trial Registration: ISRCTN Registry identifier: ISRCTN91104012

1 March 2024 in Clinical Interventions in Aging
Verified
Journal Article
Open access
PDF file
MPMatovelle Priscila
Matovelle Priscila
BOBárbara Oliván-Blázquez
Bárbara Oliván-Blázquez
MDMarta Domínguez-García
Marta Domínguez-García
VCVerónica Casado-Vicente
Verónica Casado-Vicente
BPBeatriz Pascual de la Pisa
Beatriz Pascual de la Pisa
RMRosa Magallón-Botaya
Rosa Magallón-Botaya
Background: Worldwide, chronic diseases are prevalent among the older adults, significantly affecting their health and healthcare system. The COVID-19 pandemic exacerbated these challenges, disrupting healthcare services. Our study assesses the impact on older individuals with chronic diseases who were not infected with COVID-19, analyzing comorbidities, medication use, mortality rates, and resource utilization using real data from Aragon, Spain. Methods: A retrospective observational study, conducted in Aragon, Spain, focused on individuals aged 75 and older with at least one chronic disease, who were not infected of COVID-19. The research used actual data collected during three distinct periods: the first covered the six months prior to the pandemic, the second the six months after the lockdown, and the third the period between six and twelve months. Key variables included socio-demographics, comorbidities, clinical parameters, medication use, and health services utilization. Results: We included 128.130 older adults. Mean age was 82.88 years, with 60.3% being women. The most common chronic diseases were hypertension (73.2%), dyslipidemia (52.5%), and dorsopathies (31.5%). More than 90% had more than 2 conditions. A notable decline in new chronic disease diagnoses was observed, particularly pronounced in the six to twelve months period after lockdown. Although statistically significant differences were observed in all clinical variables analyzed, they were considered clinically irrelevant. Furthermore, a decrease in healthcare services utilization and medication prescriptions was reported. Conclusion: Our study highlights a decrease in new chronic disease diagnoses, ongoing reductions in healthcare utilization, and medication prescriptions for older adults with pre-existing chronic conditions, unaffected by COVID-19.

5 March 2025 in Primary Health Care Research & Development
Verified
Journal Article
Open access
PDF file
LBLiliana Bilbie-Lupchian
Liliana Bilbie-Lupchian
BOBárbara Oliván-Blázquez
Bárbara Oliván-Blázquez
BGBeatriz González-Álvarez
Beatriz González-Álvarez
MPMatovelle Priscila
Matovelle Priscila
VCVerónica Casado-Vicente
Verónica Casado-Vicente
MSMaría Antonia Sánchez-Calavera
María Antonia Sánchez-Calavera
Objectives: To analyze the sociodemographic characteristics and trends in clinical and analytical parameters among individuals with chronic kidney disease (CKD) in Aragon (Spain), who remain uninfected with COVID-19 during the first year of pandemic. The secondary objectives were to identify the associated comorbidities and their evolution throughout the pandemic, as well as to determine the cases that got worse and their possible relationship with the control of the main risk factors. Background: CKD is a major public health problem worldwide. Studies encompassing national, European, and global contexts, show a rise in the prevalence of CKD, with a significant decrease in life quality, high morbidity and mortality, and increased healthcare costs. In this scenario, primary care is a cornerstone for the early detection of CKD and for the management of progression factors. To date, there are few publications regarding the evolution of the CKD population throughout the pandemic that are not related to hospitalizations or complications due to COVID-19. Methods: We conducted a retrospective longitudinal study with real-world data from the population over 16 years of age registered in Aragon (Spain), collecting data from electronic health records. The variables included were sociodemographic, analytical and clinical (glomerular filtration rate, cholesterol, triglycerides, glycated haemoglobin, and blood pressure) and comorbidities (hypertension, dyslipidemia, obesity, diabetes, and smoking). The data were archived and processed using the SPSS v22.0 software package. Results: During the first six months of COVID-19 pandemic, the clinical parameters of people with CKD were poorly controlled, although there was a later improvement which could be related to the progressive recovery of health services. The glycated haemoglobin value found was low, which makes us suspect possible overtreatment. There is a high prevalence of high blood pressure, diabetes, dyslipidemia, obesity and smoking. Interventions targeting these factors could help reduce the burden of CKD.